Evidence map›Paper›PMID 34412695›Full record

ArticleInfectious diseases of poverty2021

HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study.

Pablo Ryan, Jorge Valencia, Guillermo Cuevas, Jesús Troya, Juan Torres-Macho, María José Muñoz-Gómez, Nuria Muñoz-Rivas, Isabel Canorea, Sonia Vázquez-Morón, Salvador Resino

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Pablo Ryan *Hospital Universitario Infanta Leonor, Madrid, Spain.
Jorge Valencia *Hospital Universitario Infanta Leonor, Madrid, Spain.
Guillermo CuevasHospital Universitario Infanta Leonor, Madrid, Spain.
Jesús TroyaHospital Universitario Infanta Leonor, Madrid, Spain.
Juan Torres-MachoHospital Universitario Infanta Leonor, Madrid, Spain.
María José Muñoz-GómezUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda- Pozuelo, Km 2.2, 28220, Majadahonda, Madrid, Spain.
Nuria Muñoz-RivasHospital Universitario Infanta Leonor, Madrid, Spain.
Isabel CanoreaUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda- Pozuelo, Km 2.2, 28220, Majadahonda, Madrid, Spain.
Sonia Vázquez-Morón *Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda- Pozuelo, Km 2.2, 28220, Majadahonda, Madrid, Spain.
Salvador Resino *Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda- Pozuelo, Km 2.2, 28220, Majadahonda, Madrid, Spain. sresino@isciii.es.ORCID http://orcid.org/0000-0001-8783-0450
Hospital Universitario Infanta Leonor · ESInstituto de Salud Carlos III · ESUniversidad Complutense de Madrid · ES

Funding

Instituto de Salud Carlos III PI20CIII/00004Instituto de Salud Carlos III RD16CIII/0002/0002Merck Sharp and Dohme MISP IIS#54846
6 · The paper itself

Abstract

backgroundThe burden of human immunodeficiency virus (HIV) infection in people who use drugs (PWUD) is significant. We aimed to screen HIV infection among PWUD and describe their retention in HIV care. Besides, we also screen for hepatitis C virus (HCV) infection among HIV-seropositive PWUD and describe their linkage to care.

methodsWe conducted a prospective study in 529 PWUD who visited the "Cañada Real Galiana" (Madrid, Spain). The study period was from June 1, 2017, to May 31, 2018. HIV diagnosis was performed with a rapid antibody screening test at the point-of-care (POC) and HCV diagnosis with immunoassay and PCR tests on dried blood spot (DBS) in a central laboratory. Positive PWUD were referred to the hospital. We used the Chi-square or Fisher's exact tests, as appropriate, to compare rates between groups.

resultsThirty-five (6.6%) participants were positive HIV antibodies, but 34 reported previous HIV diagnoses, and 27 (76%) had prior antiretroviral therapy. Among patients with a positive HIV antibody test, we also found a higher prevalence of homeless (P < 0.001) and injection drug use (PWID) (P < 0.001), and more decades of drug use (P = 0.002). All participants received HIV test results at the POC. Of the 35 HIV positives, 28 (80%) were retained in HIV medical care at the end of the HIV screening study (2018), and only 22 (62.9%) at the end of 2020. Moreover, 12/35 (34.3%) were positive for the HCV RNA test. Of the latter, 10/12 (83.3%) were contacted to deliver the HCV results test (delivery time of 19 days), 5/12 (41.7%) had an appointment and were attended at the hospital and started HCV therapy, and only 4/12 (33.3%) cleared HCV.

conclusionsWe found almost no new HIV-infected PWUD, but their cascade of HIV care was low and remains a challenge in this population at risk. The high frequency of active hepatitis C in HIV-infected PWUD reflects the need for HCV screening and reinforcing the link to care.

Indexed as

Hepatitis CHIV InfectionsPharmaceutical PreparationsRetention in CareHepacivirusHumansProspective StudiesSpainPharmaceutical PreparationsAntiviral treatmentDried blood spotHepatitis CHIVPeople who use drugsPoint-of-careRetention in careScreening

Identifiers

PMID34412695
PMCPMC8375145
OpenAlexW3195544942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.